Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19169 | 452 | 24.6 | 52% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
434 | 15650 | CHEMOTHERAPY-TOKYO//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//CEFEPIME |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FOSFOMYCIN RESISTANCE | Author keyword | 18 | 89% | 2% | 8 |
2 | FOSFOMYCIN | Author keyword | 16 | 24% | 13% | 60 |
3 | AREA PROD PORCINA | Address | 2 | 67% | 0% | 2 |
4 | CNRS UNITE AGENTS ANTIBACTERIENS 271 | Address | 2 | 67% | 0% | 2 |
5 | DISODIUM FOSFOMYCIN | Author keyword | 1 | 100% | 0% | 2 |
6 | KPC PRODUCING KLEBSIELLA PNEUMONIAE | Author keyword | 1 | 40% | 0% | 2 |
7 | ANTIBIOTIC DETOXIFICATION | Author keyword | 1 | 50% | 0% | 1 |
8 | CLIN CIRUGIA PEQUENAS ESPECIES | Address | 1 | 50% | 0% | 1 |
9 | ELSD DETECTION | Author keyword | 1 | 50% | 0% | 1 |
10 | EMERGENCE OF DRUG RESISTANCE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROTEIN FOSA | 10 | 73% | 2% | 8 |
2 | DISODIUM FOSFOMYCIN | 9 | 83% | 1% | 5 |
3 | CALCIUM FOSFOMYCIN | 6 | 100% | 1% | 4 |
4 | PHOSPHONOMYCIN | 5 | 31% | 3% | 15 |
5 | ENCODING CTX M 14 | 4 | 75% | 1% | 3 |
6 | PHOSPHOMYCIN | 3 | 100% | 1% | 3 |
7 | INCFII PLASMIDS | 3 | 50% | 1% | 4 |
8 | GENE FOSA3 | 3 | 60% | 1% | 3 |
9 | METALLOENZYME SUPERFAMILY | 2 | 50% | 1% | 3 |
10 | ENZYME FOSA | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
The revival of fosfomycin | 2011 | 47 | 79 | 57% |
Fosfomycin: an old, new friend? | 2010 | 53 | 94 | 59% |
Fosfomycin resistance proteins: A nexus of glutathione transferases and epoxide hydrolases in a metalloenzyme superfamily | 2005 | 27 | 14 | 93% |
Fosfomycin: Use beyond urinary tract and gastrointestinal infections | 2008 | 87 | 52 | 52% |
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections | 2009 | 41 | 81 | 56% |
What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review | 2013 | 7 | 23 | 57% |
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens | 2012 | 31 | 62 | 34% |
PLASMID-ENCODED FOSFOMYCIN RESISTANCE | 1991 | 46 | 44 | 57% |
Fosfomycin for the Treatment of Resistant Gram-Negative Bacterial Infections Insights from the Society of Infectious Diseases Pharmacists | 2014 | 2 | 60 | 30% |
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies | 2009 | 22 | 72 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AREA PROD PORCINA | 2 | 67% | 0.4% | 2 |
2 | CNRS UNITE AGENTS ANTIBACTERIENS 271 | 2 | 67% | 0.4% | 2 |
3 | CLIN CIRUGIA PEQUENAS ESPECIES | 1 | 50% | 0.2% | 1 |
4 | KARL DONATH HARD TISSUE BIOMATERIAL | 1 | 50% | 0.2% | 1 |
5 | LILY | 1 | 50% | 0.2% | 1 |
6 | SETOR DOENCAS INFECCIOSAS | 1 | 50% | 0.2% | 1 |
7 | ANGIOL DIABETOL | 0 | 33% | 0.2% | 1 |
8 | PROD MANAGEMENT PROMOT | 0 | 33% | 0.2% | 1 |
9 | SEPT SURG UNIT | 0 | 15% | 0.4% | 2 |
10 | CLIN PHARMACOKINET CLIN PHARMACOL | 0 | 25% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000119339 | DIGESTIVE CARRIAGE//ESBLE//ORAL PENICILLIN |
2 | 0.0000112751 | CEFROXADINE//ABSCESS PENETRATION//RADICULAR GRANULOMA |
3 | 0.0000091116 | URINARY TRACT INFECTION//UNCOMPLICATED URINARY TRACT INFECTION//ASYMPTOMATIC BACTERIURIA |
4 | 0.0000088537 | BUNDESSTAATL BAKTERIOL SEROL UNTERSUCHUNGSANSTALT//KINDERHEILKUNDE KLIN PEDIATINFEKT ABT//ANTIMICROBIAL INTERACTION |
5 | 0.0000082106 | ALANINE RACEMASE//MURD//GLUTAMATE RACEMASE |
6 | 0.0000070324 | COLISTIN//POLYMYXINS//COLISTIMETHATE SODIUM |
7 | 0.0000065708 | MIDWIFERY MED ASSISTING//CLOSED LOOP APPROACH//FUNCT GENOM BIO CHIPS |
8 | 0.0000064437 | ERGOTHIONEINE//MYCOTHIOL//BACILLITHIOL |
9 | 0.0000064233 | CELL FATTY ACIDS//ESCHERICHIA COLIL//LIPID DEGENERATION |
10 | 0.0000062970 | TETRACYCLINE RESISTANCE PLASMID//BACTERIOPHAGE TYPING//PI9789 |